Francesco Pantano

5.5k total citations
109 papers, 2.1k citations indexed

About

Francesco Pantano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Francesco Pantano has authored 109 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 56 papers in Pulmonary and Respiratory Medicine and 26 papers in Cancer Research. Recurrent topics in Francesco Pantano's work include Bone health and treatments (29 papers), Radiopharmaceutical Chemistry and Applications (16 papers) and Cancer Diagnosis and Treatment (12 papers). Francesco Pantano is often cited by papers focused on Bone health and treatments (29 papers), Radiopharmaceutical Chemistry and Applications (16 papers) and Cancer Diagnosis and Treatment (12 papers). Francesco Pantano collaborates with scholars based in Italy, France and United States. Francesco Pantano's co-authors include Daniele Santini, Giuseppe Tonini, Bruno Vincenzi, Michele Iuliani, Alice Zoccoli, Giulia Ribelli, Sara Galluzzo, Marco Fioramonti, Emanuela Dell’Aquila and Sonia Simonetti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Francesco Pantano

99 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesco Pantano Italy 25 993 861 577 549 307 109 2.1k
Christopher D. Willey United States 28 777 0.8× 1.2k 1.4× 366 0.6× 528 1.0× 349 1.1× 118 2.5k
Bo Chen China 23 758 0.8× 875 1.0× 440 0.8× 433 0.8× 251 0.8× 114 1.9k
Deepa S. Subramaniam United States 25 922 0.9× 810 0.9× 378 0.7× 793 1.4× 205 0.7× 81 2.2k
Zan Shen China 32 1.2k 1.2× 1.2k 1.4× 632 1.1× 1.0k 1.9× 253 0.8× 155 3.1k
Qi Zhou China 26 872 0.9× 938 1.1× 518 0.9× 286 0.5× 438 1.4× 99 2.2k
Mauricio Cuello Chile 25 823 0.8× 984 1.1× 527 0.9× 280 0.5× 275 0.9× 72 2.4k
Nicky D’Haene Belgium 24 597 0.6× 610 0.7× 408 0.7× 411 0.7× 256 0.8× 95 2.0k
Pol Specenier Belgium 21 1.1k 1.1× 624 0.7× 261 0.5× 542 1.0× 206 0.7× 84 1.9k
Xing Zhang China 27 917 0.9× 1.2k 1.4× 652 1.1× 423 0.8× 327 1.1× 126 2.4k
Hong Ge China 16 873 0.9× 630 0.7× 300 0.5× 515 0.9× 446 1.5× 107 2.0k

Countries citing papers authored by Francesco Pantano

Since Specialization
Citations

This map shows the geographic impact of Francesco Pantano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Pantano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Pantano more than expected).

Fields of papers citing papers by Francesco Pantano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Pantano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Pantano. The network helps show where Francesco Pantano may publish in the future.

Co-authorship network of co-authors of Francesco Pantano

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Pantano. A scholar is included among the top collaborators of Francesco Pantano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Pantano. Francesco Pantano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Botticelli, Andrea, Alessandra Fabi, Alessandro Rossi, et al.. (2024). Trastuzumab deruxtecan in patients with breast cancer with brain metastases: The DE-REAL study.. Journal of Clinical Oncology. 42(16_suppl). 1032–1032. 1 indexed citations
2.
Salvatore, Sergio De, et al.. (2024). Clinical performance of implanted devices used in surgical treatment of patients with spinal tumors: a systematic review. BMC Musculoskeletal Disorders. 25(1). 650–650.
3.
Puppo, Margherita, Martine Croset, Davide Ceresa, et al.. (2024). Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis. Breast Cancer Research. 26(1). 186–186. 1 indexed citations
4.
Papalia, Giuseppe Francesco, Eliodoro Faiella, Domiziana Santucci, et al.. (2024). Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review. Cancers. 16(15). 2700–2700. 13 indexed citations
6.
Cursano, Maria Concetta, Emilio Francesco Giunta, Emanuela Scarpi, et al.. (2023). Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 24(15). 12436–12436. 3 indexed citations
7.
Ippolito, Edy, J. R. Infante, Francesco Pantano, et al.. (2023). PO-1270 Safety of Combination of Abemaciclib and Radiotherapy in metastatic breast cancer patients. Radiotherapy and Oncology. 182. S1015–S1015. 1 indexed citations
9.
Pantano, Francesco, Martine Croset, Keltouma Driouch, et al.. (2021). Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions. Oncogene. 40(7). 1284–1299. 69 indexed citations
10.
Ratta, Raffaele, Elena Verzoni, Alessia Mennitto, et al.. (2020). Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma. Tumori Journal. 107(6). 542–549. 7 indexed citations
11.
Fioramonti, Marco, Valentina Fausti, Francesco Pantano, et al.. (2018). Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment. Scientific Reports. 8(1). 4177–4177. 38 indexed citations
12.
Croset, Martine, Francesco Pantano, Casina W.S. Kan, et al.. (2018). miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis–Associated Genes. Cancer Research. 78(18). 5259–5273. 150 indexed citations
13.
14.
Bertani, Francesca Romana, Pamela Mozetic, Marco Fioramonti, et al.. (2017). Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis. Scientific Reports. 7(1). 8965–8965. 178 indexed citations
15.
Vincenzi, Bruno, Chiara Cremolini, Andrea Sartore‐Bianchi, et al.. (2015). Prognostic significance of KRAS mutation rate in metastatic colorectal cancer patients. Annals of Oncology. 26. vi38–vi38. 2 indexed citations
16.
Iuliani, Michele, Francesco Pantano, Consuelo Buttigliero, et al.. (2015). Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment. SHILAP Revista de lepidopterología. 11(4). 81–88.
17.
Dell’Aquila, Emanuela, Francesco Pantano, Salvatore Intagliata, et al.. (2015). Role of c-mesenchymal–epithelial transition pathway in gastric cancer. Expert Opinion on Pharmacotherapy. 16(8). 1195–1207. 11 indexed citations
18.
Santoni, Matteo, Alessandro Conti, Kalliopi Andrikou, et al.. (2015). Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials. Critical Reviews in Oncology/Hematology. 96(2). 206–219. 13 indexed citations
19.
Santini, Daniele, Sara Galluzzo, Alice Zoccoli, et al.. (2010). New molecular targets in bone metastases. Cancer Treatment Reviews. 36. S6–S10. 49 indexed citations
20.
Tonini, Giuseppe, Francesco Pantano, Bruno Vincenzi, et al.. (2007). Molecular prognostic factors in patients with pancreatic cancer. Expert Opinion on Therapeutic Targets. 11(12). 1553–1569. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026